These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25232213)

  • 1. TPX2 knockdown suppressed hepatocellular carcinoma cell invasion via inactivating AKT signaling and inhibiting MMP2 and MMP9 expression.
    Liu Q; Yang P; Tu K; Zhang H; Zheng X; Yao Y; Liu Q
    Chin J Cancer Res; 2014 Aug; 26(4):410-7. PubMed ID: 25232213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.
    Liu Q; Tu K; Zhang H; Zheng X; Yao Y; Liu Q
    Hepatol Res; 2015 Aug; 45(8):906-18. PubMed ID: 25263743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
    Huang Y; Guo W; Kan H
    Int J Mol Sci; 2014 Oct; 15(10):18148-61. PubMed ID: 25302620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.
    Gao J; Ding F; Liu Q; Yao Y
    Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
    Huang DH; Jian J; Li S; Zhang Y; Liu LZ
    Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
    Liang B; Jia C; Huang Y; He H; Li J; Liao H; Liu X; Liu X; Bai X; Yang D
    Dig Dis Sci; 2015 Aug; 60(8):2360-72. PubMed ID: 26025609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPX2 promotes cell proliferation and migration via PLK1 in OC.
    Ma S; Rong X; Gao F; Yang Y; Wei L
    Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPX2 promotes glioma cell proliferation and invasion via activation of the AKT signaling pathway.
    Gu JJ; Zhang JH; Chen HJ; Wang SS
    Oncol Lett; 2016 Dec; 12(6):5015-5022. PubMed ID: 28105208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPX2 promotes migration and invasion of human breast cancer cells.
    Yang Y; Li DP; Shen N; Yu XC; Li JB; Song Q; Zhang JH
    Asian Pac J Trop Med; 2015 Dec; 8(12):1064-1070. PubMed ID: 26706681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Methoxy-1-Tetralone Induces Apoptosis, Suppresses Cell Proliferation and Migration in Hepatocellular Carcinoma via Regulating c-Met, p-AKT, NF-κB, MMP2, and MMP9 Expression.
    Wen Y; Cai X; Chen S; Fu W; Chai D; Zhang H; Zhang Y
    Front Oncol; 2020; 10():58. PubMed ID: 32117722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
    Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
    Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPX2 regulated by miR-29c-3p induces cell proliferation in osteosarcoma via the AKT signaling pathway.
    Zhu D; Xu X; Zhang M; Wang T
    Oncol Lett; 2022 May; 23(5):143. PubMed ID: 35340555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells.
    Feng R; Ye J; Zhou C; Qi L; Fu Z; Yan B; Liang Z; Li R; Zhai W
    Diagn Pathol; 2015 Aug; 10():149. PubMed ID: 26307067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
    Dou CY; Cao CJ; Wang Z; Zhang RH; Huang LL; Lian JY; Xie WL; Wang LT
    Oncol Rep; 2016 Jun; 35(6):3489-95. PubMed ID: 27108677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
    Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
    Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.